Filed by Cimarex Energy Co.
pursuant to Rule 425 under the Securities
Act of 1933
and deemed filed pursuant to Rule 14a-12
under the Securities Exchange Act of 1934
Subject Company: Cimarex Energy Co.
Commission File No. for Registration Statement
on Form S-4 filed by Cabot Oil & Gas Corporation: 333-257534
The following communication is being filed in connection with the proposed
merger of Cimarex Energy Co. (“Cimarex”) and Cabot Oil & Gas Corporation (“Cabot”).
The following
presentation was posted to the Cimarex website on June 30, 2021.
|
Investor Presentation
Combination of Cimarex & Cabot Oil & Gas
June 2021
|
|
Combination of Cimarex and Cabot Oil & Gas
2
Creates a premier energy company delivering
leading returns on and of capital
Committed to delivering best-in-class capital
returns through commodity price cycles –
targeting 50%+ of free cash flow
Significantly increased cash generation -
$4.7bn cumulative 2022-2024 free cash flow
Strengthened financial profile & improved
cost of capital from scale, liquidity, stability &
conservative balance sheet
Low cost, high return inventory providing
capital flexibility through cycles
Commitment to ESG & sustainability leadership
› Stock-for-stock merger
› Pro forma equity ownership: 50.5% Cimarex and
49.5% Cabot on a fully diluted basis
› Executive team led by Cimarex Chairman,
President & CEO, Tom Jorden, with integration
planning underway
› Independent & diverse board comprised of 5
directors from each company
› Expected closing 4Q21
Transaction summary
|
|
A Stronger Returns Focused Energy Company
Low Cost of Supply
• Consolidating top-tier assets to create a portfolio with scale, capital
optionality & low break-evens
• 20 year average life of low-cost, high-return inventory
Accelerating Capital Returns
Well positioned to deliver enhanced
capital returns to shareholders
Low Cost of Capital & Strong Liquidity
• Strong balance sheet with maximum flexibility
• Maintain <1x net debt-to-EBITDAX
Commitment to ESG & Sustainability Leadership
• Building on proven commitments to ESG
• Linking executive compensation to ESG & value creation
• Diverse & experienced board providing ESG oversight
Substantial Cash Flow & Capital Returns
• Committing to return 50%+ of free cash flow to shareholders
• Increased resilience due to Cabot’s low decline PDP cash flows
• Capital allocation flexibility to support returns through cycles
3
INCREASING
BASE DIVIDEND
› Anticipate increasing annual dividend to
$0.50 per share
› Committed to growing over time
INTRODUCING
VARIABLE DIVIDEND
› Expect to introduce quarterly variable
dividend after closing (expect first payment
1Q22)
› Flexible mechanism for targeting a total return
of 50%+ of free cash flow
PAYING
SPECIAL DIVIDEND
› $0.50 per share special dividend expected to be
payable after closing
|
|
Accelerating Capital Returns
Significant dividend increases; implementing new dividend framework
Materially enhancing dividend payout (~3.5x higher vs. standalone)1
Standalone XEC vs. XEC shareholder’s share of pro forma cash distributions ($mm) at
mid-cycle price deck2
Pro Forma
Capital return highlights
Material increase in base dividend
to $0.50 per share ($0.125 per share
quarterly) – an 86% increase to
Cimarex shareholders
New dividend framework:
quarterly variable dividend
targeting a total return of 50%+ of
free cash flow
One-time special dividend of $0.50
per share at closing, equal to
receiving an additional annual base
dividend
Potential for future special
dividends / share repurchases
4
$106 $130 3
$206 $206 $206
$206
~$170
~$210 $220
2021e 2021e 2022e 2023e 2024e
Base Dividend Variable Dividend
1Variable dividend assumes base plus variable equals 50% of FCF
2$55/Bbl & $2.75/MMbtu
3Assume standalone 1Q to 3Q base dividends plus pro forma 4Q base dividend
Special Dividend
|
|
$40 / $2.25 $55 / $2.75
Premier Multi-Basin Exposure Drives FCF Resilience
Combined business will have an average life of >20 years of high-quality, high-return drilling locations
1Oil & natural gas play breakeven analysis assumes 25% BTAX IRRs & strip pricing as of 3/3/2021; sourced from J.P. Morgan equity research (3/16/2021)
21Q 2021 pro forma revenue contribution per basin
3Inventory years calculated as total net capital for wells with PV/I greater than 1.5x, divided by total pro forma 2021 capital; flat NYMEX WTI $/Bbl & Henry Hub NYMEX $/MMBtu
Low cost of supply assets
GAS BREAKEVENS (NYMEX $/Mcf)1
OIL BREAKEVENS (WTI $/Bbl)1
Robust inventory3
>10 years
>20 years
Resource scale maximizes capital allocation
flexibility to take advantage of commodity-
specific cycles
Cimarex team performed a thorough review
of Cabot inventory, supporting a risked
estimate life of 12-15 years of high-quality
inventory that competes with Cimarex’s near-
term inventory
› Incremental long-term upside to inventory
life across Cabot’s acreage
Delaware Basin & NE PA commodity break-
evens among the lowest cost of supply assets
› High quality portfolio with low
maintenance capital requirements
(<$35/Bbl & <$2/MMBtu prices)
Potential to enhance capital efficiency &
unlock asset value:
› Optimize field compression
› Potential co-development of Upper &
Lower Marcellus zones where Purcell frac
barrier is less prevalent/thick
› Mitigate parent/child well degradation
› Manage volumes around natural gas
seasonality
5
Cimarex technical evaluation
Click to hear more about our team’s technical
review of the Marcellus
13% 45%
42%
Revenue2
Revenue2
|
|
$1.2 $1.2 $1.2 $1.2 $1.2 $1.2 $1.2
$0.5
$1.0 $0.8
$1.3 $1.3 $1.1
$1.6 $0.4
$1.6
$1.2
$2.2 $2.2
$1.9
$2.9
$2.1
$3.8
$3.2
$4.7 $4.7
$4.2
$5.7
$40 / $2.25 $40 / $3.00 $50 / $2.25 $50 / $3.00 Mid-Cycle
($55 / $2.75)
$60 / $2.25 $60 / $3.00
Base Dividend Variable Dividend Excess FCF
Sustainable Free Cash Flow
Robust outlook for free cash flow supports the capacity for cash distributions through cycles
1Variable dividend assumes base plus variable equals 50% of FCF
Dividend framework to return cash through the cycle
FCF & implied cash distributions to shareholders at various price
scenarios
2022-2024 CUMULATIVE FCF OUTLOOK ($bn)1
Capacity & confidence to distribute >30% of CFO
6
Strong, resilient FCF profile supports
through-cycle returns & commitment
to the base dividend
Variable return commitment of 50%+
of FCF is among best-in-class for E&Ps
Capacity and confidence to distribute
>30% of CFO at higher prices
|
|
(1.0x)
(0.5x)
0.0x
0.5x
1.0x
1.5x
2.0x
2.5x
3.0x
3.5x
4.0x
- $5 $10 $15 $20 $25
YE
2021e
Net Debt / 2021e
EBITDA
Enterprise Value ($Bn)
Strong Balance Sheet
Combined scale increases liquidity, reduces volatility & improves cost of capital
Low leverage + scale
Provides significant capital optionality
Pro forma liquidity & debt maturity profile
Scale supports low cost of capital
Wtd. Avg.
Rates
Coupon 3.24% 6.25% 4.07% 4.17% 3.90% 4.38%
YTW 0.62% 1.17% 0.97% 1.56% 2.13% 2.58%
1Upstream company universe excludes companies with TEV greater than $25bn, minerals companies, offshore companies & international companies; FANG excluded from analysis
given consensus estimates do not yet fully reflect recent transactions
Smaller Scale /
Higher Leverage
Larger Scale /
Higher Leverage
Smaller Scale /
Lower Leverage
Larger Scale /
Lower Leverage
● Peer universe1
Pro Forma
7
|
|
Commitment to ESG & Sustainability Leadership
Shared commitments to environmental stewardship, sustainability & strong corporate governance
Board & Governance Sustainability
› Executive compensation to be
aligned with key strategic priorities
& performance
› CEO is waiving accelerated vesting
of equity awards in the transaction
to further align his interests with
shareholders & the success of the
merger
› Commitment to embed ESG in
compensation structure
› Commitment to independent,
diverse & experienced board
› 8 of 10 directors will be independent
› Accelerates annual election of all
directors
› Commitment to strong safety
performance & further reducing
GHG emissions
› Maintaining board-level oversight of
ESG performance & programs
› Combined business to report on ESG
performance & progress, in line with
SASB & TCFD standards
Executive Compensation
8
|
|
Maximizing Shareholder Value
9
Robust Board-
Driven Review
Resulting in a
Value-
Maximizing
Transaction
The Cimarex
board
unanimously
recommends
stockholders vote
“FOR” the
transaction
› The Board and management regularly review the market, opportunities,
investor sentiment & M&A landscape
› Over the last year, the Board considered a number of alternatives &
transactions
› Senior executives of Cimarex engaged from time to time with Cabot and
five other potential counterparties regarding strategic transactions, entering
into NDAs with two of them, including Cabot
› Transaction process with Cabot was overseen by the Cimarex Board, with
eleven meetings over four months, including many executive sessions
› Rigorous & thorough technical review of Cabot’s portfolio & future drilling
inventory
› Provides immediate upside to shareholders through more sustainable FCF
generation & substantially higher cash returns
|
|
Appendix
|
|
(76%) (70%) (57%)
60% 61% 69%
Status Quo Pro Forma PF - Optimized
Enhanced FCF Generation Risk Profile
• Analyzed 2022-2024 total cash flow across a range of prices around assumed $55 / $2.75 “mid-cycle” price case
› Analyzed commodity price ranges ($40-70 / Bbl & $2.00-$3.50 / MMBtu) represent 90% confidence interval around mid-cycle case
› Confidence interval based on statistical analysis of 15+ years of NYMEX futures contract time spreads
• “Optimized” pro forma case illustrates the new company’s ability to reallocate capital to increase overall returns while moderating growth
Increases top-end upside, decreases downside exposure & reduces mid-cycle volatility
Improved FCF Bandwidth
In low oil / low gas scenarios pro forma FCF downside is reduced;
in high oil / high gas scenarios pro forma FCF upside is increased
Mid-cycle Case
($55 & $2.75)
$70 & $3.50
$40 & $2.00
Reduced Volatility1 & Asymmetric Protection
Assuming mid-cycle gas prices, FCF volatility is significantly reduced;
downside reduction is greater in magnitude than upside reduction
(61%)
(36%) (27%)
49%
29% 32%
Status Quo Pro Forma PF - Optimized
Mid-cycle Case
($55 & $2.75)
$70 & $2.75
$40 & $2.75
110% 64% 59%
20% upside
reduction vs. XEC
17% upside
reduction vs. XEC
Optimized Optimized
25% downside
reduction vs. XEC
35% downside
reduction vs. XEC
11
1Defined as the arithmetic spread between the high oil and low oil price case at constant mid-cycle gas price
|
|
Disclaimers
12
Cautionary Statement Regarding Forward-Looking Information
This communication contains certain forward-looking statements within the meaning of federal securities laws. Words such as anticipates, believes, expects, intends, plans, outlook, will, should, may and similar
expressions may be used to identify forward-looking statements. Forward-looking statements are not statements of historical fact and reflect Cabot’s and Cimarex’s current views about future events. Such
forward-looking statements include, but are not limited to, statements about the benefits of the proposed merger involving Cabot and Cimarex, including future financial and operating results; Cabot’s and
Cimarex’s plans, objectives, expectations and intentions; the expected timing and likelihood of completion of the transaction; the expected timing and amount of any future dividends; and other statements that
are not historical facts, including estimates of oil and natural gas reserves and resources, estimates of future production, assumptions regarding future oil and natural gas pricing, planned drilling activity, future
results of operations, projected cash flow and liquidity, the achievement of synergies, business strategy and other plans and objectives for future operations. No assurances can be given that the forward-looking
statements contained in this communication will occur as projected and actual results may differ materially from those projected. Forward-looking statements are based on current expectations, estimates and
assumptions that involve a number of risks and uncertainties that could cause actual results to differ materially from those projected. These risks and uncertainties include, without limitation, the ability to obtain
the requisite Cabot and Cimarex stockholder approvals; the risk that Cabot or Cimarex may be unable to obtain governmental and regulatory approvals required for the merger; the risk that an event, change or
other circumstances could give rise to the termination of the proposed merger; the risk that a condition to closing of the merger may not be satisfied on a timely basis or at all; the length of time necessary to close
the proposed transaction, which may be longer than anticipated for various reasons; the risk that the businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the
transaction may not be fully realized or may take longer to realize than expected; the risk that any announcement relating to the proposed transaction could have adverse effects on the market price of Cabot’s
common stock or Cimarex’s common stock; the risk of litigation related to the proposed transaction; the effect of future regulatory or legislative actions on the companies or the industry in which they operate,
including the risk of new restrictions with respect to well spacing, hydraulic fracturing, natural gas flaring or other oil and natural gas development activities; the risk that the credit ratings of the combined business
may be different from what the companies expect; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; the diversion of management time on
merger-related issues; the volatility in commodity prices for crude oil and natural gas; the continuing effects of the COVID-19 pandemic and the impact thereof on Cabot’s and Cimarex’s businesses, financial
condition and results of operations; actions by, or disputes among or between, the Organization of Petroleum Exporting Countries and other producer countries; the presence or recoverability of estimated
reserves; the ability to replace reserves; environmental risks; drilling and operating risks; exploration and development risks; competition; the ability of management to execute its plans to meet its goals; and other
risks inherent in Cabot’s and Cimarex’s businesses. In addition, the declaration and payment of any future dividends, whether regular base quarterly dividends, variable dividends or special dividends following
completion of the proposed transaction, will depend on the combined business financial results, cash requirements, future prospects and other factors deemed relevant by the board of directors of Cabot (as then
constituted). These risks, as well as other risks related to the proposed transaction, are described in the registration statement on Form S-4 and preliminary joint proxy statement/prospectus that was filed with the
SEC and the definitive joint proxy statement/prospectus if and when it becomes available in connection with the proposed transaction. While the list of factors presented here is, and the list of factors to be
presented in the registration statement on Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Should one or more of
these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual outcomes may vary materially from those indicated. For additional information about other factors that could cause
actual results to differ materially from those described in the forward-looking statements, please refer to: (1) Cabot’s annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K,
which are available on Cabot’s website at www.cabotog.com/investorrelations and on the SECs website at http://www.sec.gov; and (2) Cimarex’s annual reports on Form 10-K, quarterly reports on Form 10-Q and
current reports on Form 8-K, which are available on its website at www.cimarex.com/investor-relations and on the SECs website at http://www.sec.gov.
Forward-looking statements are based on the estimates and opinions of management at the time the statements are made. Except to the extent required by applicable law, neither Cabot nor Cimarex undertakes
any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on these forward-
looking statements that speak only as of the date hereof.
|
|
Disclaimers
13
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there be any sale of
securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. No offering of securities shall be made,
except by means of a prospectus meeting the requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Additional Information about the Merger and Where to Find It
In connection with the proposed transaction, Cabot filed with the SEC a registration statement on Form S-4 on June 29, 2021, that includes a preliminary joint proxy statement of Cabot and Cimarex and that also
constitutes a preliminary prospectus of Cabot. If and when the registration statement becomes effective and the joint proxy statement/prospectus is in definitive form, such joint proxy statement/prospectus will
be sent to the stockholders of Cabot and Cimarex. Each of Cabot and Cimarex also intends to file other relevant documents with the SEC regarding the proposed transaction, including the definitive joint proxy
statement/prospectus. The information in the preliminary joint proxy statement/prospectus is not complete and may be changed. This communication is not a substitute for the preliminary joint proxy
statement/prospectus or registration statement or any other document that Cabot or Cimarex may file with the SEC. The definitive joint proxy statement/prospectus (if and when available) will be mailed to
stockholders of Cabot and Cimarex. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE PRELIMINARY JOINT PROXY STATEMENT/PROSPECTUS, THE DEFINITIVE
JOINT PROXY STATEMENT/PROSPECTUS IF AND WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR
SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CABOT, CIMAREX AND THE PROPOSED
TRANSACTION. Investors and security holders are able to obtain free copies of the registration statement and preliminary joint proxy statement/prospectus and all other documents containing important
information about Cabot, Cimarex and the proposed transaction, once such documents are filed with the SEC, including the definitive joint proxy statement/prospectus if and when it becomes available, through
the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Cabot may be obtained free of charge on Cabot’s website at www.cabotog.com/investor-relations or by
contacting Matt Kerin by email at matt.kerin@cabotog.com or by phone at 281-589-4642. Copies of the documents filed with the SEC by Cimarex may be obtained free of charge on Cimarex’s website at
www.cimarex.com/investor-relations.
Participants in the Solicitation
Cabot, Cimarex and certain of their respective directors and executive officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information about the directors
and executive officers of Cabot, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Cabot’s proxy statement for its 2021 Annual Meeting of Stockholders,
which was filed with the SEC on March 12, 2021, and Cabot’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC on February 26, 2021. Information about the
directors and executive officers of Cimarex, including a description of their direct or indirect interests, by security holdings or otherwise, is set forth in Cimarex’s proxy statement for its 2021 Annual Meeting of
Stockholders, which was filed with the SEC on March 26, 2021, and Cimarex’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC on February 23, 2021. Investors
may obtain additional information regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction by reading the preliminary joint proxy
statement/prospectus, including any amendments thereto, as well as the definitive joint proxy statement/prospectus if and when it becomes available and other relevant materials to be filed with the SEC regarding
the proposed transaction when such materials become available. Investors should read the preliminary joint proxy statement/prospectus, and the definitive joint proxy statement/prospectus if and when it
becomes available, carefully before making any voting or investment decisions. You may obtain free copies of these documents from Cabot or Cimarex using the sources indicated above.
|
Cautionary Statement Regarding Forward-Looking Information
This communication contains certain forward-looking statements within
the meaning of federal securities laws. Words such as anticipates, believes, expects, intends, plans, outlook, will, should, may and similar
expressions may be used to identify forward-looking statements. Forward-looking statements are not statements of historical fact and reflect
Cabot’s and Cimarex’s current views about future events. Such forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving Cabot and Cimarex, including future financial and operating results;
Cabot’s and Cimarex’s plans, objectives, expectations and intentions; the expected timing and likelihood of completion
of the transaction; the expected timing and amount of any future dividends; and other statements that are not historical facts,
including estimates of oil and natural gas reserves and resources, estimates of future production, assumptions regarding future oil and
natural gas pricing, planned drilling activity, future results of operations, projected cash flow and liquidity, the achievement of synergies,
business strategy and other plans and objectives for future operations. No assurances can be given that the forward-looking statements
contained in this communication will occur as projected and actual results may differ materially from those projected. Forward-looking
statements are based on current expectations, estimates and assumptions that involve a number of risks and uncertainties that could cause
actual results to differ materially from those projected. These risks and uncertainties include, without limitation, the ability to obtain
the requisite Cabot and Cimarex stockholder approvals; the risk that Cabot or Cimarex may be unable to obtain governmental and regulatory
approvals required for the merger; the risk that an event, change or other circumstances could give rise to the termination of the
proposed merger; the risk that a condition to closing of the merger may not be satisfied on a timely basis or at all; the length
of time necessary to close the proposed transaction, which may be longer than anticipated for various reasons; the risk that the
businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the transaction may not
be fully realized or may take longer to realize than expected; the risk that any announcement relating to the proposed transaction
could have adverse effects on the market price of Cabot’s common stock or Cimarex’s common stock; the risk of litigation
related to the proposed transaction; the effect of future regulatory or legislative actions on the companies or the industry in which
they operate, including the risk of new restrictions with respect to well spacing, hydraulic fracturing, natural gas flaring or other
oil and natural gas development activities; the risk that the credit ratings of the combined business may be different from what
the companies expect; disruption from the transaction making it more difficult to maintain relationships with customers, employees
or suppliers; the diversion of management time on merger-related issues; the volatility in commodity prices for crude oil and
natural gas; the continuing effects of the COVID-19 pandemic and the impact thereof on Cabot’s and Cimarex’s businesses,
financial condition and results of operations; actions by, or disputes among or between, the Organization of Petroleum Exporting
Countries and other producer countries; the presence or recoverability of estimated reserves; the ability to replace reserves;
environmental risks; drilling and operating risks; exploration and development risks; competition; the ability of
management to execute its plans to meet its goals; and other risks inherent in Cabot’s and Cimarex’s businesses. In addition,
the declaration and payment of any future dividends, whether regular base quarterly dividends, variable dividends or special dividends
following completion of the proposed transaction, will depend on the combined business financial results, cash requirements, future prospects
and other factors deemed relevant by the board of directors of Cabot (as then constituted). These risks, as well as other risks related
to the proposed transaction, are described in the registration statement on Form S-4 and preliminary joint proxy statement/prospectus
that was filed with the SEC and the definitive joint proxy statement/prospectus if and when it becomes available in connection with the
proposed transaction. While the list of factors presented here is, and the list of factors to be presented in the registration statement
on Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and
uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual
outcomes may vary materially from those indicated. For additional information about other factors that could cause actual results to differ
materially from those described in the forward-looking statements, please refer to: (1) Cabot’s annual reports on Form 10-K,
quarterly reports on Form 10-Q and current reports on Form 8-K, which are available on Cabot’s website at www.cabotog.com/investorrelations
and on the SECs website at http://www.sec.gov; and (2) Cimarex’s annual reports on Form 10-K, quarterly reports on
Form 10-Q and current reports on Form 8-K, which are available on its website at www.cimarex.com/investor-relations and on the
SECs website at http://www.sec.gov.
Forward-looking statements are based on the estimates and opinions
of management at the time the statements are made. Except to the extent required by applicable law, neither Cabot nor Cimarex undertakes
any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer
to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there
be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the
requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Additional Information about the Merger and Where to Find It
In connection with the proposed transaction, Cabot filed with the SEC
a registration statement on Form S-4 on June 29, 2021, that includes a preliminary joint proxy statement of Cabot and Cimarex
and that also constitutes a preliminary prospectus of Cabot. If and when the registration statement becomes effective and the joint proxy
statement/prospectus is in definitive form, such joint proxy statement/prospectus will be sent to the stockholders of Cabot and Cimarex.
Each of Cabot and Cimarex also intends to file other relevant documents with the SEC regarding the proposed transaction, including the
definitive joint proxy statement/prospectus. The information in the preliminary joint proxy statement/prospectus is not complete and may
be changed. This communication is not a substitute for the preliminary joint proxy statement/prospectus or registration statement or any
other document that Cabot or Cimarex may file with the SEC. The definitive joint proxy statement/prospectus (if and when available) will
be mailed to stockholders of Cabot and Cimarex. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE PRELIMINARY
JOINT PROXY STATEMENT/PROSPECTUS, THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS IF AND WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT
DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY
BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CABOT, CIMAREX AND THE PROPOSED TRANSACTION. Investors and security holders
are able to obtain free copies of the registration statement and preliminary joint proxy statement/prospectus and all other documents
containing important information about Cabot, Cimarex and the proposed transaction, once such documents are filed with the SEC, including
the definitive joint proxy statement/prospectus if and when it becomes available, through the website maintained by the SEC at http://www.sec.gov.
Copies of the documents filed with the SEC by Cabot may be obtained free of charge on Cabot’s website at www.cabotog.com/investor-relations
or by contacting Matt Kerin by email at matt.kerin@cabotog.com or by phone at 281-589-4642. Copies of the documents filed with the SEC
by Cimarex may be obtained free of charge on Cimarex’s website at www.cimarex.com/investor-relations.
Participants in the Solicitation
Cabot, Cimarex and certain of their respective directors and executive
officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information about the
directors and executive officers of Cabot, including a description of their direct or indirect interests, by security holdings or otherwise,
is set forth in Cabot’s proxy statement for its 2021 Annual Meeting of Stockholders, which was filed with the SEC on March 12,
2021, and Cabot’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC
on February 26, 2021. Information about the directors and executive officers of Cimarex, including a description of their direct
or indirect interests, by security holdings or otherwise, is set forth in Cimarex’s proxy statement for its 2021 Annual Meeting
of Stockholders, which was filed with the SEC on March 26, 2021, and Cimarex’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2020, which was filed with the SEC on February 23, 2021. Investors may obtain additional information
regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction by reading the preliminary
joint proxy statement/prospectus, including any amendments thereto, as well as the definitive joint proxy statement/prospectus if and
when it becomes available and other relevant materials to be filed with the SEC regarding the proposed transaction when such materials
become available. Investors should read the preliminary joint proxy statement/prospectus, and the definitive joint proxy statement/prospectus
if and when it becomes available, carefully before making any voting or investment decisions. You may obtain free copies of these documents
from Cabot or Cimarex using the sources indicated above.
The following is a transcript from a video posted to the Cimarex
website on June 30, 2021.
Corporate Participant
Bryan Phillips
Manager, Asset Evaluation Team, Cimarex Energy Co.
Hi, I’m Bryan Phillips, the Manager of Cimarex’s Asset
Evaluation Team.
Our team is composed of experienced individuals with backgrounds in
geology, geophysics, petrophysics, engineering, land and data analytics. Our full-time job is to evaluate opportunities for acquisition
and divestiture, evaluating operators who are best-in-class in basins all across the United States.
For Cabot we performed a thorough technical analysis. We mapped the
Upper and Lower Marcellus, we forecast every producing well, we generated our own independent type curves to assess the value of remaining
inventory, as well as assessing the quantity of that remaining inventory, we reviewed Cabot’s marketing contracts and their production
operations, including compression optimization.
Our executive team and our Board members were with us every step of
the way. And together, we concluded that Cabot is a tier-one position and that the two companies together were better than the sum of
our parts.
The Lower Marcellus is fully delineated across Cabot’s position
and has been developed under a consistent spacing since 2017. We generated our type curves from the last three years of proven drilling
results.
One observation that we had is that it is unusual for wells to be as
productive as they are on Cabot’s acreage at such a shallow depth. Our target depth across most of Cabot’s acreage is around
7,000 feet deep. To get similar gas productivity in the Haynesville or Woodford Shale, we typically drill a mile deeper, which adds drilling
costs, completion costs, technical complexity and risk.
To verify Cabot’s inventory in the Lower Marcellus, we first
calculated the drainage radius of every producing well. Then we subtracted that from Cabot’s acreage position. Using the same spacing
as Cabot, we calculated how many wells remained to be drilled, and this corroborated Cabot’s internal estimates.
Here’s a map that shows the wells Cabot has drilled in the Lower
Marcellus. We subdivided Cabot’s acreage position into five type curve areas. Number one is their best geologic position with the
most productive wells, and thus the best economic outcomes. What’s exciting to us, as you can see here, is that the highest percentage
of remaining inventory in the Lower Marcellus is in type curve area one.
The Purcell Limestone is an important feature in the geologic framework
of the area. This separates the Upper from the Lower Marcellus. We analyzed two dozen pairs of Upper and Lower Marcellus landings in close
proximity to each other and determined that the Purcell is a competent frac barrier between them. In the areas where we’ve placed
value in the Upper Marcellus, the Purcell is at least 50 feet thick. This gives us the flexibility to co-develop the two reservoirs or
develop them separately.
The Upper Marcellus is approximately the same thickness as the Lower
Marcellus. As you can see on this map, Cabot has drilled more than 50 wells in the Upper Marcellus, proving that the Upper Marcellus is
a productive gas reservoir across the scope of Cabot’s acreage. These results, combined with offset operators and our geological
and petrophysical efforts, allowed us to high-grade the Upper Marcellus potential on Cabot’s acreage. The lack of wells allows us
to treat this as a blank canvas. We can develop this asset optimally using 2021 best practices, including two- to three-mile wells and
optimal completion designs.
We have only placed value on the Upper Marcellus locations inside this
red polygon, which compete with Cimarex’s near-term inventory. Longer-term inventory, which exists outside this polygon, is upside
to our asset evaluation.
In short, Cabot has built a tremendous asset. We’re excited to
bring it together with our existing portfolio, and we look forward to the collaboration of the two technical teams.
Cautionary Statement Regarding Forward-Looking Information
This communication contains certain forward-looking statements within
the meaning of federal securities laws. Words such as anticipates, believes, expects, intends, plans, outlook, will, should, may and similar
expressions may be used to identify forward-looking statements. Forward-looking statements are not statements of historical fact and reflect
Cabot’s and Cimarex’s current views about future events. Such forward-looking statements include, but are not limited to,
statements about the benefits of the proposed merger involving Cabot and Cimarex, including future financial and operating results;
Cabot’s and Cimarex’s plans, objectives, expectations and intentions; the expected timing and likelihood of completion
of the transaction; the expected timing and amount of any future dividends; and other statements that are not historical facts,
including estimates of oil and natural gas reserves and resources, estimates of future production, assumptions regarding future oil and
natural gas pricing, planned drilling activity, future results of operations, projected cash flow and liquidity, the achievement of synergies,
business strategy and other plans and objectives for future operations. No assurances can be given that the forward-looking statements
contained in this communication will occur as projected and actual results may differ materially from those projected. Forward-looking
statements are based on current expectations, estimates and assumptions that involve a number of risks and uncertainties that could cause
actual results to differ materially from those projected. These risks and uncertainties include, without limitation, the ability to obtain
the requisite Cabot and Cimarex stockholder approvals; the risk that Cabot or Cimarex may be unable to obtain governmental and regulatory
approvals required for the merger; the risk that an event, change or other circumstances could give rise to the termination of the
proposed merger; the risk that a condition to closing of the merger may not be satisfied on a timely basis or at all; the length
of time necessary to close the proposed transaction, which may be longer than anticipated for various reasons; the risk that the
businesses will not be integrated successfully; the risk that the cost savings and any other synergies from the transaction may not
be fully realized or may take longer to realize than expected; the risk that any announcement relating to the proposed transaction
could have adverse effects on the market price of Cabot’s common stock or Cimarex’s common stock; the risk of litigation
related to the proposed transaction; the effect of future regulatory or legislative actions on the companies or the industry in which
they operate, including the risk of new restrictions with respect to well spacing, hydraulic fracturing, natural gas flaring or other
oil and natural gas development activities; the risk that the credit ratings of the combined business may be different from what
the companies expect; disruption from the transaction making it more difficult to maintain relationships with customers, employees
or suppliers; the diversion of management time on merger-related issues; the volatility in commodity prices for crude oil and
natural gas; the continuing effects of the COVID-19 pandemic and the impact thereof on Cabot’s and Cimarex’s businesses,
financial condition and results of operations; actions by, or disputes among or between, the Organization of Petroleum Exporting
Countries and other producer countries; the presence or recoverability of estimated reserves; the ability to replace reserves;
environmental risks; drilling and operating risks; exploration and development risks; competition; the ability of
management to execute its plans to meet its goals; and other risks inherent in Cabot’s and Cimarex’s businesses. In addition,
the declaration and payment of any future dividends, whether regular base quarterly dividends, variable dividends or special dividends
following completion of the proposed transaction, will depend on the combined business financial results, cash requirements, future prospects
and other factors deemed relevant by the board of directors of Cabot (as then constituted). These risks, as well as other risks related
to the proposed transaction, are described in the registration statement on Form S-4 and preliminary joint proxy statement/prospectus
that was filed with the SEC and the definitive joint proxy statement/prospectus if and when it becomes available in connection with the
proposed transaction. While the list of factors presented here is, and the list of factors to be presented in the registration statement
on Form S-4 are, considered representative, no such list should be considered to be a complete statement of all potential risks and
uncertainties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual
outcomes may vary materially from those indicated. For additional information about other factors that could cause actual results to differ
materially from those described in the forward-looking statements, please refer to: (1) Cabot’s annual reports on Form 10-K,
quarterly reports on Form 10-Q and current reports on Form 8-K, which are available on Cabot’s website at www.cabotog.com/investorrelations
and on the SECs website at http://www.sec.gov; and (2) Cimarex’s annual reports on Form 10-K, quarterly reports on
Form 10-Q and current reports on Form 8-K, which are available on its website at www.cimarex.com/investor-relations and on the
SECs website at http://www.sec.gov.
Forward-looking statements are based on the estimates and opinions
of management at the time the statements are made. Except to the extent required by applicable law, neither Cabot nor Cimarex undertakes
any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof.
No Offer or Solicitation
This communication is not intended to and shall not constitute an offer
to buy or sell or the solicitation of an offer to buy or sell any securities, or a solicitation of any vote or approval, nor shall there
be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification
under the securities laws of any such jurisdiction. No offering of securities shall be made, except by means of a prospectus meeting the
requirements of Section 10 of the U.S. Securities Act of 1933, as amended.
Additional Information about the Merger and Where to Find It
In connection with the proposed transaction, Cabot filed with the SEC
a registration statement on Form S-4 on June 29, 2021, that includes a preliminary joint proxy statement of Cabot and Cimarex
and that also constitutes a preliminary prospectus of Cabot. If and when the registration statement becomes effective and the joint proxy
statement/prospectus is in definitive form, such joint proxy statement/prospectus will be sent to the stockholders of Cabot and Cimarex.
Each of Cabot and Cimarex also intends to file other relevant documents with the SEC regarding the proposed transaction, including the
definitive joint proxy statement/prospectus. The information in the preliminary joint proxy statement/prospectus is not complete and may
be changed. This communication is not a substitute for the preliminary joint proxy statement/prospectus or registration statement or any
other document that Cabot or Cimarex may file with the SEC. The definitive joint proxy statement/prospectus (if and when available) will
be mailed to stockholders of Cabot and Cimarex. INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE REGISTRATION STATEMENT, THE PRELIMINARY
JOINT PROXY STATEMENT/PROSPECTUS, THE DEFINITIVE JOINT PROXY STATEMENT/PROSPECTUS IF AND WHEN IT BECOMES AVAILABLE AND ANY OTHER RELEVANT
DOCUMENTS THAT MAY BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, CAREFULLY AND IN THEIR ENTIRETY
BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT CABOT, CIMAREX AND THE PROPOSED TRANSACTION. Investors and security holders
are able to obtain free copies of the registration statement and preliminary joint proxy statement/prospectus and all other documents
containing important information about Cabot, Cimarex and the proposed transaction, once such documents are filed with the SEC, including
the definitive joint proxy statement/prospectus if and when it becomes available, through the website maintained by the SEC at http://www.sec.gov.
Copies of the documents filed with the SEC by Cabot may be obtained free of charge on Cabot’s website at www.cabotog.com/investor-relations
or by contacting Matt Kerin by email at matt.kerin@cabotog.com or by phone at 281-589-4642. Copies of the documents filed with the SEC
by Cimarex may be obtained free of charge on Cimarex’s website at www.cimarex.com/investor-relations.
Participants in the Solicitation
Cabot, Cimarex and certain of their respective directors and executive
officers may be deemed to be participants in the solicitation of proxies in respect of the proposed transaction. Information about the
directors and executive officers of Cabot, including a description of their direct or indirect interests, by security holdings or otherwise,
is set forth in Cabot’s proxy statement for its 2021 Annual Meeting of Stockholders, which was filed with the SEC on March 12,
2021, and Cabot’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, which was filed with the SEC
on February 26, 2021. Information about the directors and executive officers of Cimarex, including a description of their direct
or indirect interests, by security holdings or otherwise, is set forth in Cimarex’s proxy statement for its 2021 Annual Meeting
of Stockholders, which was filed with the SEC on March 26, 2021, and Cimarex’s Annual Report on Form 10-K for the fiscal
year ended December 31, 2020, which was filed with the SEC on February 23, 2021. Investors may obtain additional information
regarding the interests of those persons and other persons who may be deemed participants in the proposed transaction by reading the preliminary
joint proxy statement/prospectus, including any amendments thereto, as well as the definitive joint proxy statement/prospectus if and
when it becomes available and other relevant materials to be filed with the SEC regarding the proposed transaction when such materials
become available. Investors should read the preliminary joint proxy statement/prospectus, and the definitive joint proxy statement/prospectus
if and when it becomes available, carefully before making any voting or investment decisions. You may obtain free copies of these documents
from Cabot or Cimarex using the sources indicated above.
Cimarex Energy (NYSE:XEC)
Gráfica de Acción Histórica
De Nov 2024 a Dic 2024
Cimarex Energy (NYSE:XEC)
Gráfica de Acción Histórica
De Dic 2023 a Dic 2024